Mark Chatterley – Page 13

Nexage advertises for series C round

The Singtel Innov8-backed mobile advertising company has raised $19.5m so far, and aims to close a series C round in the next two months.

GE Pension Trust helps Verdasys unlock funding

Data security firm Verdasys has taken its overall funding past $65m with a round backed by GE Pension Trust

Demandbase commands $15m investment

Adobe has invested in another round raised by US-based B2B marketing and personalisation platform Demandbase, after investing in its $10m series C and $15m series D rounds.

OpenTable acquires Ness Computing

OpenTable, an online restaurant reservation provider, has acquired SingTel and Amex-backed Ness Computing, a US-based provider of personalised restaurant recommendations, for $17.2m.

$37.2m for NephroGenex in IPO

NephroGenex has closed an initial public offering of 3.1 million shares of common stock.

Genocea Biosciences closes IPO

US-based Genocea Biosciences has raised an approximate net value of $61.4m from selling 5.5 millions shares of common stock at a price of $12 per share in an initial public offering.

Flexion Therapeutics, a US-based biotechnology company currently advancing a portfolio of injectable analgesic drug candidates, has sold 5.750 million shares of common stock in their initial public offering (IPO). The shares were offered at a price of $13 per share for an initial market cap of around $192m. BMO Capital Markets and Wells Fargo Securities… Continue reading IPO injection for Flexion

$103.5m for Dicerna Pharmaceuticals

US-based biopharmaceutical company Dicerna Pharmaceuticals has closed their initial public offering selling 6.9 million shares of common stock.

Chukong seeks $150m high score

Chinese mobile game developer Chukong Technologies is preparing a $150m US initial public offering.

$19m for Biocept in IPO

Molecular oncology diagnostics company Biocept has raised $19m in their initial public offering by selling 1.9 million shares of common stock.

Celladon raises $50.6m in IPO

US-based cardiovascular drug developer Celladon has raised $50.6m in their initial public offering selling 6.325 million shares at $8 each.

Trigence semiconductor sale sounds good

Japanese chip design company Trigence Semiconductor has agreed to sell a minority stake to the state-run Innovation Network Corporation of Japan (INCJ).

Apple acquires Burstly

Burstly, a smartphone app development company responsible for the beta-testing platform TestFlight, has been acquired by Apple.

3M lights up MSi

3M has invested an undisclosed amount in MSi Lighting, a US-based company that offers an alternative to traditional halogen light bulbs.